ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alinia (nitazoxanide) Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-39P9003
Home | Market Reports
Global Alinia nitazoxanide Market Insights and Forecast to 2028
BUY CHAPTERS

Global Alinia (nitazoxanide) Market Research Report 2026

Code: QYRE-Auto-39P9003
Report
2026-04-10
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Romark Laboratories
Chugai Pharmaceutical
Lupin Ltd
Rising
Zenara

Alinia (nitazoxanide) Market Size

The global Alinia (nitazoxanide) market was valued at US$ 197 million in 2025 and is anticipated to reach US$ 247 million by 2032, at a CAGR of 3.3% from 2026 to 2032.

Alinia (nitazoxanide) Market

Alinia (nitazoxanide) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Alinia (nitazoxanide) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
The Alinia (nitazoxanide) market is primarily driven by the increasing prevalence of parasitic infections and gastrointestinal diseases worldwide. Nitazoxanide, a broad-spectrum anti-parasitic and anti-protozoal drug, is effective in treating infections like giardiasis, amebiasis, and other intestinal parasitic infections. The growing awareness of these diseases, especially in regions with poor sanitation and healthcare infrastructure, contributes to the demand for Alinia. Additionally, its effectiveness against a range of pathogens, including protozoa and some viral infections, positions it as a vital treatment option for physicians in endemic areas. As international health organizations push for better treatment solutions for neglected tropical diseases, the global need for Alinia continues to rise.
However, the Alinia market faces challenges related to its high cost and limited availability in certain regions. While nitazoxanide is effective, its price may be prohibitive for patients in low-income countries, where parasitic infections are most prevalent. This pricing issue is further compounded by competition from cheaper generic alternatives and the availability of other medications for similar conditions. Moreover, despite its broad-spectrum efficacy, Alinia’s usage is limited to specific conditions, and it is not always the first-line treatment, especially in more developed regions where other, more widely used drugs are available. Additionally, regulatory hurdles and approval processes in certain markets could hinder broader adoption, particularly in developing countries where access to essential medicines remains a challenge.
The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.
This report delivers a comprehensive overview of the global Alinia (nitazoxanide) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Alinia (nitazoxanide). The Alinia (nitazoxanide) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Alinia (nitazoxanide) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Alinia (nitazoxanide) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Alinia (nitazoxanide) Market Report

Report Metric Details
Report Name Alinia (nitazoxanide) Market
Accounted market size in 2025 US$ 197 million
Forecasted market size in 2032 US$ 247 million
CAGR 3.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Tablets
  • Oral Suspension
by Application
  • Retail Pharmacy
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Romark Laboratories, Chugai Pharmaceutical, Lupin, RISING, ZENARA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Alinia (nitazoxanide) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Alinia (nitazoxanide) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Alinia (nitazoxanide) Market growing?

Ans: The Alinia (nitazoxanide) Market witnessing a CAGR of 3.3% during the forecast period 2026-2032.

What is the Alinia (nitazoxanide) Market size in 2032?

Ans: The Alinia (nitazoxanide) Market size in 2032 will be US$ 247 million.

What is the market share of major companies in Alinia (nitazoxanide) Market?

Ans: The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market.

What is the Alinia (nitazoxanide) Market share by type?

Ans: In terms of Type, Tablets is the largest segment, with a share about 99%.

Who are the main players in the Alinia (nitazoxanide) Market report?

Ans: The main players in the Alinia (nitazoxanide) Market are Romark Laboratories, Chugai Pharmaceutical, Lupin, RISING, ZENARA

What are the Application segmentation covered in the Alinia (nitazoxanide) Market report?

Ans: The Applications covered in the Alinia (nitazoxanide) Market report are Retail Pharmacy, Hospital, Others

What are the Type segmentation covered in the Alinia (nitazoxanide) Market report?

Ans: The Types covered in the Alinia (nitazoxanide) Market report are Tablets, Oral Suspension

1 Alinia (nitazoxanide) Market Overview
1.1 Product Definition
1.2 Alinia (nitazoxanide) by Type
1.2.1 Global Alinia (nitazoxanide) Market Value by Type: 2025 vs 2032
1.2.2 Tablets
1.2.3 Oral Suspension
1.3 Alinia (nitazoxanide) by Application
1.3.1 Global Alinia (nitazoxanide) Market Value by Application: 2025 vs 2032
1.3.2 Retail Pharmacy
1.3.3 Hospital
1.3.4 Others
1.4 Global Alinia (nitazoxanide) Market Size Estimates and Forecasts
1.4.1 Global Alinia (nitazoxanide) Revenue 2021–2032
1.4.2 Global Alinia (nitazoxanide) Sales 2021–2032
1.4.3 Global Alinia (nitazoxanide) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Alinia (nitazoxanide) Market Competition by Manufacturers
2.1 Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Alinia (nitazoxanide) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Alinia (nitazoxanide) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Alinia (nitazoxanide), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Alinia (nitazoxanide), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Alinia (nitazoxanide), Product Types and Applications
2.7 Global Key Manufacturers of Alinia (nitazoxanide), Date of Entry into the Industry
2.8 Global Alinia (nitazoxanide) Market Competitive Situation and Trends
2.8.1 Global Alinia (nitazoxanide) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Alinia (nitazoxanide) Players Market Share by Revenue
2.8.3 Global Alinia (nitazoxanide) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alinia (nitazoxanide) Market Scenario by Region
3.1 Global Alinia (nitazoxanide) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Alinia (nitazoxanide) Sales by Region: 2021–2032
3.2.1 Global Alinia (nitazoxanide) Sales by Region: 2021–2026
3.2.2 Global Alinia (nitazoxanide) Sales by Region: 2027–2032
3.3 Global Alinia (nitazoxanide) Revenue by Region: 2021–2032
3.3.1 Global Alinia (nitazoxanide) Revenue by Region: 2021–2026
3.3.2 Global Alinia (nitazoxanide) Revenue by Region: 2027–2032
3.4 North America Alinia (nitazoxanide) Market Facts & Figures by Country
3.4.1 North America Alinia (nitazoxanide) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Alinia (nitazoxanide) Sales by Country (2021–2032)
3.4.3 North America Alinia (nitazoxanide) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alinia (nitazoxanide) Market Facts & Figures by Country
3.5.1 Europe Alinia (nitazoxanide) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Alinia (nitazoxanide) Sales by Country (2021–2032)
3.5.3 Europe Alinia (nitazoxanide) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alinia (nitazoxanide) Market Facts & Figures by Region
3.6.1 Asia Pacific Alinia (nitazoxanide) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Alinia (nitazoxanide) Sales by Region (2021–2032)
3.6.3 Asia Pacific Alinia (nitazoxanide) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alinia (nitazoxanide) Market Facts & Figures by Country
3.7.1 Latin America Alinia (nitazoxanide) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Alinia (nitazoxanide) Sales by Country (2021–2032)
3.7.3 Latin America Alinia (nitazoxanide) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alinia (nitazoxanide) Market Facts & Figures by Country
3.8.1 Middle East and Africa Alinia (nitazoxanide) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Alinia (nitazoxanide) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Alinia (nitazoxanide) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alinia (nitazoxanide) Sales by Type (2021–2032)
4.1.1 Global Alinia (nitazoxanide) Sales by Type (2021–2026)
4.1.2 Global Alinia (nitazoxanide) Sales by Type (2027–2032)
4.1.3 Global Alinia (nitazoxanide) Sales Market Share by Type (2021–2032)
4.2 Global Alinia (nitazoxanide) Revenue by Type (2021–2032)
4.2.1 Global Alinia (nitazoxanide) Revenue by Type (2021–2026)
4.2.2 Global Alinia (nitazoxanide) Revenue by Type (2027–2032)
4.2.3 Global Alinia (nitazoxanide) Revenue Market Share by Type (2021–2032)
4.3 Global Alinia (nitazoxanide) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Alinia (nitazoxanide) Sales by Application (2021–2032)
5.1.1 Global Alinia (nitazoxanide) Sales by Application (2021–2026)
5.1.2 Global Alinia (nitazoxanide) Sales by Application (2027–2032)
5.1.3 Global Alinia (nitazoxanide) Sales Market Share by Application (2021–2032)
5.2 Global Alinia (nitazoxanide) Revenue by Application (2021–2032)
5.2.1 Global Alinia (nitazoxanide) Revenue by Application (2021–2026)
5.2.2 Global Alinia (nitazoxanide) Revenue by Application (2027–2032)
5.2.3 Global Alinia (nitazoxanide) Revenue Market Share by Application (2021–2032)
5.3 Global Alinia (nitazoxanide) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Romark Laboratories
6.1.1 Romark Laboratories Company Information
6.1.2 Romark Laboratories Description and Business Overview
6.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Romark Laboratories Alinia (nitazoxanide) Product Portfolio
6.1.5 Romark Laboratories Recent Developments/Updates
6.2 Chugai Pharmaceutical
6.2.1 Chugai Pharmaceutical Company Information
6.2.2 Chugai Pharmaceutical Description and Business Overview
6.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio
6.2.5 Chugai Pharmaceutical Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Company Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Lupin Alinia (nitazoxanide) Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 RISING
6.4.1 RISING Company Information
6.4.2 RISING Description and Business Overview
6.4.3 RISING Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 RISING Alinia (nitazoxanide) Product Portfolio
6.4.5 RISING Recent Developments/Updates
6.5 ZENARA
6.5.1 ZENARA Company Information
6.5.2 ZENARA Description and Business Overview
6.5.3 ZENARA Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 ZENARA Alinia (nitazoxanide) Product Portfolio
6.5.5 ZENARA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alinia (nitazoxanide) Industry Chain Analysis
7.2 Alinia (nitazoxanide) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alinia (nitazoxanide) Production Mode & Process Analysis
7.4 Alinia (nitazoxanide) Sales and Marketing
7.4.1 Alinia (nitazoxanide) Sales Channels
7.4.2 Alinia (nitazoxanide) Distributors
7.5 Alinia (nitazoxanide) Customer Analysis
8 Alinia (nitazoxanide) Market Dynamics
8.1 Alinia (nitazoxanide) Industry Trends
8.2 Alinia (nitazoxanide) Market Drivers
8.3 Alinia (nitazoxanide) Market Challenges
8.4 Alinia (nitazoxanide) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Romark Laboratories
Chugai Pharmaceutical
Lupin Ltd
Rising
Zenara
List of Tables
 Table 1. Global Alinia (nitazoxanide) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Alinia (nitazoxanide) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Alinia (nitazoxanide) Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Alinia (nitazoxanide) Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Alinia (nitazoxanide) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Alinia (nitazoxanide) Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Alinia (nitazoxanide) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Alinia (nitazoxanide), Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Alinia (nitazoxanide), Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Alinia (nitazoxanide), Product Types and Applications
 Table 12. Global Key Manufacturers of Alinia (nitazoxanide), Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alinia (nitazoxanide) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Alinia (nitazoxanide) Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alinia (nitazoxanide) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Alinia (nitazoxanide) Sales by Region (K Units), 2021–2026
 Table 18. Global Alinia (nitazoxanide) Sales Market Share by Region (2021–2026)
 Table 19. Global Alinia (nitazoxanide) Sales by Region (K Units), 2027–2032
 Table 20. Global Alinia (nitazoxanide) Sales Market Share by Region (2027–2032)
 Table 21. Global Alinia (nitazoxanide) Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Alinia (nitazoxanide) Revenue Market Share by Region (2021–2026)
 Table 23. Global Alinia (nitazoxanide) Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Alinia (nitazoxanide) Revenue Market Share by Region (2027–2032)
 Table 25. North America Alinia (nitazoxanide) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Alinia (nitazoxanide) Sales by Country (K Units), 2021–2026
 Table 27. North America Alinia (nitazoxanide) Sales by Country (K Units), 2027–2032
 Table 28. North America Alinia (nitazoxanide) Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Alinia (nitazoxanide) Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Alinia (nitazoxanide) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Alinia (nitazoxanide) Sales by Country (K Units), 2021–2026
 Table 32. Europe Alinia (nitazoxanide) Sales by Country (K Units), 2027–2032
 Table 33. Europe Alinia (nitazoxanide) Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Alinia (nitazoxanide) Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Alinia (nitazoxanide) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Alinia (nitazoxanide) Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Alinia (nitazoxanide) Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Alinia (nitazoxanide) Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Alinia (nitazoxanide) Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Alinia (nitazoxanide) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Alinia (nitazoxanide) Sales by Country (K Units), 2021–2026
 Table 42. Latin America Alinia (nitazoxanide) Sales by Country (K Units), 2027–2032
 Table 43. Latin America Alinia (nitazoxanide) Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Alinia (nitazoxanide) Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Alinia (nitazoxanide) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Alinia (nitazoxanide) Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Alinia (nitazoxanide) Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Alinia (nitazoxanide) Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Alinia (nitazoxanide) Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Alinia (nitazoxanide) Sales (K Units) by Type (2021–2026)
 Table 51. Global Alinia (nitazoxanide) Sales (K Units) by Type (2027–2032)
 Table 52. Global Alinia (nitazoxanide) Sales Market Share by Type (2021–2026)
 Table 53. Global Alinia (nitazoxanide) Sales Market Share by Type (2027–2032)
 Table 54. Global Alinia (nitazoxanide) Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Alinia (nitazoxanide) Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Alinia (nitazoxanide) Revenue Market Share by Type (2021–2026)
 Table 57. Global Alinia (nitazoxanide) Revenue Market Share by Type (2027–2032)
 Table 58. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Alinia (nitazoxanide) Sales (K Units) by Application (2021–2026)
 Table 61. Global Alinia (nitazoxanide) Sales (K Units) by Application (2027–2032)
 Table 62. Global Alinia (nitazoxanide) Sales Market Share by Application (2021–2026)
 Table 63. Global Alinia (nitazoxanide) Sales Market Share by Application (2027–2032)
 Table 64. Global Alinia (nitazoxanide) Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Alinia (nitazoxanide) Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Alinia (nitazoxanide) Revenue Market Share by Application (2021–2026)
 Table 67. Global Alinia (nitazoxanide) Revenue Market Share by Application (2027–2032)
 Table 68. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2027–2032)
 Table 70. Romark Laboratories Company Information
 Table 71. Romark Laboratories Description and Business Overview
 Table 72. Romark Laboratories Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Romark Laboratories Alinia (nitazoxanide) Product
 Table 74. Romark Laboratories Recent Developments/Updates
 Table 75. Chugai Pharmaceutical Company Information
 Table 76. Chugai Pharmaceutical Description and Business Overview
 Table 77. Chugai Pharmaceutical Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Chugai Pharmaceutical Alinia (nitazoxanide) Product
 Table 79. Chugai Pharmaceutical Recent Developments/Updates
 Table 80. Lupin Company Information
 Table 81. Lupin Description and Business Overview
 Table 82. Lupin Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Lupin Alinia (nitazoxanide) Product
 Table 84. Lupin Recent Developments/Updates
 Table 85. RISING Company Information
 Table 86. RISING Description and Business Overview
 Table 87. RISING Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. RISING Alinia (nitazoxanide) Product
 Table 89. RISING Recent Developments/Updates
 Table 90. ZENARA Company Information
 Table 91. ZENARA Description and Business Overview
 Table 92. ZENARA Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. ZENARA Alinia (nitazoxanide) Product
 Table 94. ZENARA Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Alinia (nitazoxanide) Distributors List
 Table 98. Alinia (nitazoxanide) Customers List
 Table 99. Alinia (nitazoxanide) Market Trends
 Table 100. Alinia (nitazoxanide) Market Drivers
 Table 101. Alinia (nitazoxanide) Market Challenges
 Table 102. Alinia (nitazoxanide) Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alinia (nitazoxanide)
 Figure 2. Global Alinia (nitazoxanide) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Alinia (nitazoxanide) Market Share by Type: 2025 & 2032
 Figure 4. Tablets Product Picture
 Figure 5. Oral Suspension Product Picture
 Figure 6. Global Alinia (nitazoxanide) Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Alinia (nitazoxanide) Market Share by Application: 2025 & 2032
 Figure 8. Retail Pharmacy
 Figure 9. Hospital
 Figure 10. Others
 Figure 11. Global Alinia (nitazoxanide) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Alinia (nitazoxanide) Market Size (US$ Million), 2021–2032
 Figure 13. Global Alinia (nitazoxanide) Sales (K Units), 2021–2032
 Figure 14. Global Alinia (nitazoxanide) Average Price (US$/Unit), 2021–2032
 Figure 15. Alinia (nitazoxanide) Report Years Considered
 Figure 16. Alinia (nitazoxanide) Sales Share by Manufacturers in 2025
 Figure 17. Global Alinia (nitazoxanide) Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Alinia (nitazoxanide) Players: Market Share by Revenue in Alinia (nitazoxanide) in 2025
 Figure 19. Alinia (nitazoxanide) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Alinia (nitazoxanide) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Alinia (nitazoxanide) Sales Market Share by Country (2021–2032)
 Figure 22. North America Alinia (nitazoxanide) Revenue Market Share by Country (2021–2032)
 Figure 23. United States Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Alinia (nitazoxanide) Sales Market Share by Country (2021–2032)
 Figure 26. Europe Alinia (nitazoxanide) Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Alinia (nitazoxanide) Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Alinia (nitazoxanide) Revenue Market Share by Region (2021–2032)
 Figure 34. China Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Alinia (nitazoxanide) Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Alinia (nitazoxanide) Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Alinia (nitazoxanide) Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Alinia (nitazoxanide) Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Alinia (nitazoxanide) by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Alinia (nitazoxanide) by Type (2021–2032)
 Figure 55. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Alinia (nitazoxanide) by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Alinia (nitazoxanide) by Application (2021–2032)
 Figure 58. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2021–2032)
 Figure 59. Alinia (nitazoxanide) Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Tinidazole Tablet Market Insights Forecast to 2030
Global Ornidazole Capsules Market Research Report 2024
Global Metronidazole Market Research Report 2025
Global Isavuconazonium Sulfate Medicine Market Research Report 2024
Global Albendazole Tablets Market Research Report 2024
Albendazole Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025
Nitazoxanide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rifaximin Market Insights Forecast to 2030
Acetazolamide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tindamax Market Insights Forecast to 2030
Global Anticoccidial Solutions Market Research Report 2024
Global Tiabendazole Market Research Report 2024
Global Coccidiosis Treatment Market Research Report 2024
Global Diclazuril Veterinary Drug API Market Research Report 2024
Coccidiostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Afoxolaner Market Research Report 2024
Global Oxyclozanide Market Research Report 2025
Global Atipamazole Hydrochloride Market Research Report 2025
Global Itraconazole Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions